


Medical Diet Consultants has operated in New York, NY since 1984, providing medically supervised weight loss programs that integrate prescription medications, structured nutrition protocols, and individualized counseling. The clinic's four-decade presence in Manhattan reflects a sustained focus on evidence-based weight management for patients seeking clinical oversight rather than commercial diet programs. Medical Diet Consultants serves adults across the five boroughs who require pharmaceutical intervention combined with dietary modification to achieve measurable weight reduction.
The clinic now incorporates tirzepatide into its treatment protocols, a dual GIP/GLP-1 receptor agonist that addresses both glucose regulation and appetite suppression through distinct hormonal pathways. Tirzepatide therapy at Medical Diet Consultants follows FDA-approved dosing schedules with weekly subcutaneous administration, typically initiated at 2.5 mg and titrated based on patient response and tolerance. This peptide therapy complements the clinic's established prescription appetite suppressant options, providing an alternative mechanism for patients who have not responded adequately to traditional sympathomimetic agents or who present with concurrent metabolic concerns. The medical team evaluates candidates for tirzepatide based on BMI criteria, contraindication screening, and compatibility with existing medications, ensuring appropriate patient selection for this incretin-based approach.
Medical Diet Consultants conducts all consultations and follow-up appointments in-person at its New York location, requiring patients to attend regular visits for medication management, progress assessment, and nutritional counseling adjustments. The clinic's physicians perform initial medical evaluations including laboratory work to establish baseline metabolic parameters and identify any conditions that would preclude certain weight loss medications. Nutrition counseling sessions address caloric targets, macronutrient distribution, meal timing strategies, and behavioral modification techniques specific to each patient's lifestyle constraints and food preferences. This structured approach provides accountability through scheduled weigh-ins and direct provider interaction rather than remote monitoring.
Patients beginning treatment at Medical Diet Consultants undergo comprehensive intake appointments that include medical history review, physical examination, discussion of previous weight loss attempts, and establishment of realistic goal parameters. The clinic's protocols emphasize gradual, sustainable weight reduction rather than rapid loss, with typical programs spanning several months and including planned transition phases as patients approach target weights. Follow-up visits occur at intervals determined by the specific medication regimen, with tirzepatide patients generally seen every four weeks during dose escalation and maintenance phases. The medical team monitors for common side effects associated with GLP-1 receptor agonists, including gastrointestinal symptoms, and adjusts treatment plans accordingly.
With a 5.0-star rating across 25 Google reviews, Medical Diet Consultants maintains consistent patient feedback regarding goal achievement and program structure. The clinic's longevity in New York's competitive medical weight loss market demonstrates sustained demand for physician-supervised programs that combine pharmaceutical intervention with nutritional guidance. Medical Diet Consultants does not offer telehealth services, positioning itself for patients who prefer face-to-face medical oversight and are able to commit to regular in-office appointments throughout their weight loss journey. The clinic's Manhattan location provides access for patients throughout New York, NY and surrounding areas seeking medically managed weight reduction with peptide therapy options.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


